Literature DB >> 29871821

Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?

Paul Ametsbichler1, Antje Böhlandt2, Dennis Nowak3, Rudolf Schierl4.   

Abstract

INTRODUCTION: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a new promising treatment for patients with peritoneal carcinomatosis. It is supposed to provide a higher local drug concentration and deeper penetrate into the tumor tissue compared to systemic chemotherapy or hyperthermic intraperitoneal chemotherapy perfusion (HIPEC). Due to the application of cytotoxic drug aerosols within the operating room (OR), concern has been raised regarding the occupational exposure risk of the involved OR staff.
MATERIALS AND METHODS: In this study, an OR workplace monitoring was performed during 14 PIPAC procedures in two hospitals by collecting air samples (n = 14) during PIPAC and wipe samples (n = 223) before and after PIPAC: 56 samples from the OR floor, 84 from the injector, 28 from trocars and 55 from gloves. All samples were analyzed for platinum (Pt).
RESULTS: While air Pt concentrations were below 3.1 pg/m³, surface contaminations widely varied between 0.01 pg/cm2 and 1733 pg/cm2 (median 1.04 pg/cm2), with substantial Pt concentrations on injector parts (i.e. syringe holder) and trocars. Floors and particularly injectors were often higher contaminated before compared to after PIPAC, probably due to inefficient cleaning or cross-contamination. Glove samples taken after different tasks ranged between 0.04 and 423 pg/cm2 (median 0.58 pg/cm2).
CONCLUSION: Contamination on various OR surfaces widely ranged and can lead to a distribution of cytotoxic drug residues. However, the air contamination was very low. The results indicate that PIPAC performance seems to be possible with low occupational exposure risk, but adequate safety and cleaning standards for PIPAC must be developed and monitored.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Contamination; Environmental monitoring; Occupational exposure; PIPAC; Peritoneal carcinomatosis; Platinum

Mesh:

Substances:

Year:  2018        PMID: 29871821     DOI: 10.1016/j.ejso.2018.05.020

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  13 in total

Review 1.  Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview.

Authors:  Miguel Alberto; Andreas Brandl; Pankaj Kumar Garg; Safak Gül-Klein; Mathias Dahlmann; Ulrike Stein; Beate Rau
Journal:  Clin Exp Metastasis       Date:  2019-02-04       Impact factor: 5.150

Review 2.  The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review.

Authors:  Robin J Lurvink; Kurt Van der Speeten; Koen P Rovers; Ignace H J T de Hingh
Journal:  J Gastrointest Oncol       Date:  2021-04

3.  PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.

Authors:  Mustafa Raoof; Gautam Malhotra; Adrian Kohut; Michael O'Leary; Paul Frankel; Thuy Tran; Marwan Fakih; Joseph Chao; Dean Lim; Yanghee Woo; Isaac B Paz; Michael Lew; Mihaela C Cristea; Lorna Rodriguez-Rodriguez; Yuman Fong; Andrew Blakely; Richard Whelan; Marc A Reymond; Amit Merchea; Thanh H Dellinger
Journal:  Ann Surg Oncol       Date:  2021-08-13       Impact factor: 5.344

4.  Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.

Authors:  Florian Struller; Philipp Horvath; Wiebke Solass; Frank-Jürgen Weinreich; Dirk Strumberg; Marios K Kokkalis; Imma Fischer; Christoph Meisner; Alfred Königsrainer; Marc A Reymond
Journal:  Ther Adv Med Oncol       Date:  2019-05-13       Impact factor: 8.168

5.  Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).

Authors:  Koen P Rovers; Robin J Lurvink; Emma Ce Wassenaar; Thomas Jm Kootstra; Harm J Scholten; Rudaba Tajzai; Maarten J Deenen; Joost Nederend; Max J Lahaye; Clément Jr Huysentruyt; Iris van 't Erve; Remond Ja Fijneman; Alexander Constantinides; Onno Kranenburg; Maartje Los; Anna Mj Thijs; Geert-Jan M Creemers; Jacobus Wa Burger; Marinus J Wiezer; Djamila Boerma; Simon W Nienhuijs; Ignace Hjt de Hingh
Journal:  BMJ Open       Date:  2019-07-27       Impact factor: 2.692

6.  Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy.

Authors:  Arnaud Girardot-Miglierina; Daniel Clerc; Mohammad Alyami; Laurent Villeneuve; Olivia Sgarbura; Marc-André Reymond; Martin Hübner
Journal:  Pleura Peritoneum       Date:  2021-11-02

7.  Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum.

Authors:  Soo Jin Park; Eun Ji Lee; Hee Su Lee; Junsik Kim; Sunwoo Park; Jiyeon Ham; Jaehee Mun; Haerin Paik; Hyunji Lim; Aeran Seol; Ga Won Yim; Seung-Hyuk Shim; Beong-Cheol Kang; Suk Joon Chang; Whasun Lim; Gwonhwa Song; Jae-Weon Kim; Nara Lee; Ji Won Park; Jung Chan Lee; Hee Seung Kim
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 8.  Pressurized intraperitoneal aerosol chemotherapy: a review of the introduction of a new surgical technology using the IDEAL framework.

Authors:  S J Tate; J Torkington
Journal:  BJS Open       Date:  2020-01-19

9.  Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy.

Authors:  Till Markowiak; Michael Ried; Christopher Larisch; Dennis Nowak; Hans-Stefan Hofmann; Stefan Rakete
Journal:  Int Arch Occup Environ Health       Date:  2021-06-30       Impact factor: 3.015

10.  Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: results of the IP-OR international survey.

Authors:  Daniel Clerc; Martin Hübner; K R Ashwin; S P Somashekhar; Beate Rau; Wim Ceelen; Wouter Willaert; Naoual Bakrin; Nathalie Laplace; Mohammed Al Hosni; Edgar Luis Garcia Lozcano; Sebastian Blaj; Pompiliu Piso; Andrea Di Giorgio; Giuseppe Vizzelli; Cécile Brigand; Jean-Baptiste Delhorme; Amandine Klipfel; Rami Archid; Giorgi Nadiradze; Marc A Reymond; Olivia Sgarbura
Journal:  Pleura Peritoneum       Date:  2021-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.